NUWE übertreffen die 16 der letzten 36Schätzungen.
44%
Nächster Bericht
Datum des nächsten Berichts
09. März 2026
Estimate forQ4 25(Revenue/ EPS)
$2.36M
/
-$1.59
Implizierte Änderung vonQ3 25(Revenue/ EPS)
--
/
--
Implizierte Änderung vonQ4 24(Revenue/ EPS)
+1.47%
/
-94.59%
Nuwellis, Inc. Common Stock earnings per share and revenue
On 12. Nov. 2025, NUWE reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.41 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 2.55 million, with a --% difference. The market reacted with a -3.96% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -1.59 USD, with revenue projected to reach 2.36 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
06. Jan. 2026 For Q2 26
Estimate
-$0.10
Aktuell
$0.00
Überraschung
+100.00%
FAQ
What were Nuwellis, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Nuwellis, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Nuwellis, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -3.96%, changed from $2.78 before the earnings release to $2.67 the day after.
When is Nuwellis, Inc. Common Stock expected to report next?
The next earning report is scheduled for 09. März 2026.
What are the forecasts for Nuwellis, Inc. Common Stock's next earnings report?
Based on 3
analysts, Nuwellis, Inc. Common Stock is expected to report EPS of -$1.59 and revenue of $2.36M for Q4 2025.